<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="we have selected single stranded negative- and positive-sense RNA viruses," exact="influenza" post="virus, and rhinovirus, respectively, which annually cause respiratory illnesses"/>
 <result pre="cellular proteins and expression of housekeeping genes. The titers of" exact="influenza" post="A (H1N1pdm) virus and human rhinovirus serotype 1A were"/>
 <result pre="were reduced by 40% and 65%, respectively. A preincubation of" exact="influenza" post="virus with binase before infection significantly reduced viral titer"/>
 <result pre="reduced viral titer after single-cycle replication of the virus. Using" exact="influenza" post="A virus mini genome system we showed that binase"/>
 <result pre="stranded RNA viruses, such as negative-sense Ebola, Marburg, Lassa, and" exact="influenza" post="and positive-sense human immunodeficiency viruses, are very important human"/>
 <result pre="RNA viruses like Ebola, corona, Zika, and different strains of" exact="influenza" post="A viruses. Among RNA viruses, the respiratory viruses are"/>
 <result pre="and cause annually worldwide epidemics and occasional pandemic outbreaks. The" exact="influenza" post="A virus even without a pandemic outbreak kills up"/>
 <result pre="human rhinoviruses (HRV) which are the major cause of the" exact="common cold." post="HRV infections are suffered by everyone. Recent reports suggest"/>
 <result pre="inactivated or attenuated antigenic material of viruses helps to prevent" exact="influenza" post="illness or to reduce its impact in individuals. There"/>
 <result pre="its impact in individuals. There is no permanent vaccination against" exact="influenza" post="virus and each year countries lose a large amount"/>
 <result pre="types of medicinal products for the prevention and treatment of" exact="influenza" post="infections. Currently, there is no vaccine against HRV ["/>
 <result pre="that quickly normalized the state and decreased the symptoms of" exact="meningitis" post="and cerebrospinal pleocytosis in patients with tick borne encephalitis"/>
 <result pre="of meningitis and cerebrospinal pleocytosis in patients with tick borne" exact="encephalitis" post="[ 6]. Shortcoming of mammalian RNases is their affinity"/>
 <result pre="We have demonstrated that binase reduced the titer of pandemic" exact="influenza" post="A/Hamburg/4/2009 (H1N1pdm), reovirus serotype 1 (Reo 1-Lang), herpes virus"/>
 <result pre="(MDBK) epithelial cells, human fetal lung fibroblast (MRC5) cells, and" exact="hepatocellular carcinoma" post="(Huh7) cells, respectively [ 9– 11]. Influenza viruses contain"/>
 <result pre="at 37°C in a 5% CO 2 atmosphere. The pandemic" exact="influenza" post="A/Hamburg/04/09 (H1N1pdm) and human rhinovirus serotype 1A (HRV1A) were"/>
 <result pre="3′- and 5′-noncoding region of the NS RNA segment of" exact="influenza" post="A/WSN/33 virus [ 2] placed between a truncated human"/>
 <result pre="between a truncated human RNA polymerase I promotor (POLI) and" exact="hepatitis" post="delta virus ribozyme (R). The expressed subunits of the"/>
 <result pre="of the viral polymerases and nucleoprotein replicated and transcribed the" exact="influenza" post="virus-like RNA expressed by pPOLI-GFP-RT into mRNA. To perform"/>
 <result pre="ATA AC-3′) were used to identify the binase effect on" exact="influenza" post="A viral RNA using real-time RT-PCR. 2.13. RNA Extraction"/>
 <result pre="(binase-treated) samples data. The ΔCt value of the calibrator from" exact="influenza" post="virus-infected and binase nontreated cells (Ct target (Ct value"/>
 <result pre="in A549 cells)) and ΔCt value of the test from" exact="influenza" post="virus-infected and binase-treated cells (Ct target − Ct reference)"/>
 <result pre="a P value of &amp;lt;0.05. 2.17. Biosafety All experiments involving" exact="influenza" post="A (H1N1pdm) and rhinovirus serotype 1A (HRV1A) were performed"/>
 <result pre="ribonuclease binase on infectious titer of negative-sense single stranded RNA" exact="influenza" post="A (H1N1pdm) virus after its single-cycle replication in A549"/>
 <result pre="and NP genes of H1N1pdm viral RNP complex and an" exact="influenza" post="virus-like RNA encoding a GFP reporter protein (see Sections"/>
 <result pre="scheme reflecting different possible mechanisms of a binase effect on" exact="influenza" post="A viral functional ribonucleoprotein (RNP) complex gene expression using"/>
 <result pre="complex, which is essential for the replication and transcription of" exact="influenza" post="virus RNA. Novel small molecule compounds which inhibited the"/>
 <result pre="viral replication and include inhibitors of human immunodeficiency virus (HIV)," exact="hepatitis" post="C virus (HCV), severe acute respiratory syndrome coronavirus (SARS"/>
 <result pre="inhibitors of human immunodeficiency virus (HIV), hepatitis C virus (HCV)," exact="severe acute respiratory syndrome" post="coronavirus (SARS CoV), and influenza A virus [ 20]."/>
 <result pre="virus (HCV), severe acute respiratory syndrome coronavirus (SARS CoV), and" exact="influenza" post="A virus [ 20]. Highly conserved noncoding RNA (ncRNA)"/>
 <result pre="viruses can be targeted by binase. The +ssRNA transcript of" exact="influenza" post="virus is used as mRNA for the synthesis of"/>
 <result pre="does not need to be transported into the nucleus; the" exact="influenza" post="+ssRNA is also located in the cytoplasm. Cytoplasmic allocation"/>
 <result pre="Palese P. Garcia-Sastre A. A plasmid-based reverse genetics system for" exact="influenza" post="A virus Journal of Virology 1996 70 6 4188"/>
 <result pre="P. Canter V. M. Salganik R. I. Ribonuclease treatment of" exact="tick-borne encephalitis" post="Archives of Neurology 1976 33 9 598 603 10.1001/archneur.1976.00500090004002"/>
 <result pre="Canter V. M. Salganik R. I. Ribonuclease treatment of tick-borne" exact="encephalitis" post="Archives of Neurology 1976 33 9 598 603 10.1001/archneur.1976.00500090004002"/>
 <result pre="Ilinskaya O. N. Antiviral activity of binase against the pandemic" exact="influenza" post="A (H1N1) virus Acta Naturae 2013 5 19 44"/>
 <result pre="J. Pleschka S. Improved dual promotor-driven reverse genetics system for" exact="influenza" post="viruses Journal of Virological Methods 2013 193 2 603"/>
 <result pre="Neumann G. Watanabe T. Ito H. et al. Generation of" exact="influenza" post="A viruses entirely from cloned cDNAs Proceedings of the"/>
 <result pre="RNA polymerase I-polymerase II transcription system for the generation of" exact="influenza" post="A virus from eight plasmids Journal of General Virology"/>
 <result pre="19 Faburay B. Richt J. A. Short interfering RNA inhibits" exact="rift valley fever" post="virus replication and degradation of protein kinase R in"/>
 <result pre="Screening for novel small molecule inhibitors targeting the assembling of" exact="influenza" post="virus polymerase complex by a BiLC-based reporter system Journal"/>
 <result pre="formation monitored by GFP fluorescence in the cells using the" exact="influenza" post="A virus mini genome system. For the in vitro"/>
 <result pre="3′- and 5′-noncoding region of the NS RNA segment of" exact="influenza" post="A/WSN/33 virus [ 2] placed between a truncated human"/>
 <result pre="between a truncated human RNA polymerase I promotor (POLI) and" exact="hepatitis" post="delta virus ribozyme (R). The expressed subunits of the"/>
 <result pre="of the viral polymerases and nucleoprotein replicate and transcribe the" exact="influenza" post="virus-like RNA expressed by pPOLI-GFP-RT into GFP mRNA, resulting"/>
 <result pre="and (D) inhibitory effect of binase on the expression of" exact="influenza" post="A virus mini genome system in cytoplasm and nucleus,"/>
</results>
